SOLV
SOLVAC NOM(RETAIL)Evidence as of 2026-09-03Moneyta sentiment
Where the published evidence leans after the desk debated it — not a rating or a recommendation.
−0.1 on a −2 to +2 scale.
What builds the score
Solid bars are analyst rubric scores; faded bars are computed directly from data. Claims dropped in debate count for nothing; weakened claims count at half weight.
Editor's note
Written after the debate settled — the rest of the page is the evidence behind it.
The evidence balance is Mixed ( -0.1 of a possible +2 ) with high confidence. Reported revenues were 2,096,000,000 for the quarter ended 30 September 2025 (Q3 2025), 2,007,000,000 for the quarter ended 31 March 2026 (Q1 2026), and 2,209,000,000 for the fiscal quarter ended 2026-07-31 (Q2 2026). Gross profit rose across those same dates from 1,135,000,000 to 1,109,700,000 to 1,286,000,000, implying gross margins of about 54.2%, 55.3%, and 58.2% respectively.
Net income shows large quarter-to-quarter variation at 1,266,000,000 for Q3 2025, 13,000,000 for Q1 2026, and 92,000,000 for Q2 2026, and diluted EPS moved from 7.22 to 0.07 to 0.53. Cash and cash equivalents declined across reported dates from 1,642,000,000 as of 30 September 2025 to 403,000,000 as of 30 June 2026, while long-term debt trended lower from 5,137,000,000 to 4,573,000,000 over the same span. Valuation metrics in the packet show trailing twelve‑month P/E of 11.03, EV/EBITDA of 7.47 with an enterprise value of 20,275,560,695, P/FCF of 36.95 and an implied FCF growth rate of 24.65% consistent with the price input used; reported cash is materially smaller than reported long‑term debt.
How this note was made
every stage ran before the note was writtenAnalyst desk
Mercer, Oakes, Nash, Ellis, Yates, Talbot and Archer. The desk: named AI agents, not people. Each reads one slice of the evidence and nothing else — no outside knowledge, no browsing — so every finding traces to a source you can open.
Reads the XBRL figures companies file with the SEC — revenue, margins, income, debt and share count, quarter by quarter — and reports which way the trend is running.
Reported revenues were 2,096,000,000 for the quarter ended 30 September 2025, 2,007,000,000 for the quarter ended 31 March 2026, and 2,209,000,000 for the quarter ended 30 June 2026.
XBRL companyfacts · 0001964738-25-000091Gross profit was 1,135,000,000 for the quarter ended 30 September 2025, 1,109,700,000 for the quarter ended 31 March 2026, and 1,286,000,000 for the quarter ended 30 June 2026; those correspond to gross margins of about 54.2% (1,135 / 2,096), 55.3% (1,109.7 / 2,007), and 58.2% (1,286 / 2,209) respectively.
XBRL companyfacts · 0001964738-25-000091Reads the filings themselves, above all the year-over-year diff of Item 1A risk factors: which risks a company added, dropped or quietly reworded since its last annual report.
Nothing in this slice of the evidence rose to a claim — a quiet read, which itself is information.
Which filings the desk reads
The desk reads the annual 10-K in full — its risk factors, and how they changed since last year. Quarterly 10-Qs and event filings (8-Ks, insider Form 4s) are listed for context but not read line by line: the 10-K is where the material risk disclosures live. A brand-new company, or one we have only just begun tracking, may have no annual report on file yet — its risk analysis fills in once that lands.
Reads the signal panel above — momentum, volatility, drawdown, relative strength and beta — and ranks each against the whole research universe rather than judging it in isolation.
No computed signal history for this symbol yet — signals need roughly 70 trading days of price history.
Reads which funds hold the name and at what weight, plus insider Form 4 filings, to show the exposure you may already carry through index funds.
As of 2026-09-02T13:45:47.228469+00:00, SOLV had a 0.02% weight in the ETF identified as IVV.
ETF constituents · market dataReads recent headlines that are genuinely about this company, ignoring rating chatter and market-wide stories. Findings argue in the debate but never move the sentiment score.
Several recent headlines highlight improving growth and stronger earnings outlook for SOLV while also flagging heavy debt and margin risks into 2027.
News · finance.yahoo.com · 2026-09-02Zacks-published headlines emphasize earnings growth and price strength for Solventum, framing the company as noteworthy to watch.
News · zacks.com · 2026-09-02Reads parsed Forms 3/4/5 — who bought or sold, at what size, and whether a 10b5-1 plan was involved. Flags clustered open-market officer buying; treats plan sales as routine and never counts a fund or 10%-holder as an officer.
No SEC identity on file for this symbol — insider filings cannot be looked up.
Reads the implied-expectations math built from the company's own filings (the growth rate today's price would justify, and the multiples beside it) and argues whether the market's bar looks high or low for this business. Never turns the math into a target.
The model reports an implied free-cash-flow (FCF) growth rate of 24.65% that today’s price would justify under the stated discount and terminal assumptions.
Valuation inputs · SEC XBRL + stored EOD closeTrailing twelve-month price-to-earnings (P/E) is 11.03 based on the provided earnings per share and price.
Valuation inputs · SEC XBRL + stored EOD closeDebate and risk review
A bull and a bear contest the claims and the chair rules on each; the risk review stress-tests what survived.
A bull and a bear argue the analysts' claims across two rounds, then a chair rules on each one. Only what survives feeds the score — the argument is shown, not hidden, so you can judge the reasoning yourself.
The filing-level revenue and gross-profit figures are internally consistent and show sequential top-line stability with expanding gross margins (claims fundamentals-0 and fundamentals-1), which is a strong foundational signal in the SEC-sourced data. Diluted share counts and point-in-time outstanding shares declined (fundamentals-4) while the company repurchased stock in the March quarter (fundamentals-6), giving earnings-per-share leverage to operating improvements even where net-income swung (fundamentals-2/3). Market-value metrics reported by the model—trailing P/E of ~11 and EV/EBITDA ~7.5 (valuation-1 and valuation-2)—constitute objectively low multiples versus many peers and support a favorable valuation read given the documented revenue and margin profile. Relevant headlines and partnership reporting (news-1 and news-2) provide corroborating operational context in public coverage. The data showing cash declines and reported volatility in net income are real issues to factor in (contested below), but the filing and valuation evidence together supply a coherent case for a favorable interpretation of the company’s current operating and valuation posture.
Chair's verdict, claim by claim
Fragility · computed, not argued
balanced0.38
21 surviving claims rest on 10 distinct sources; the heaviest analyst carries 38% of them, and 98% of what the desk raised survived the debate.
The evidence base is moderately concentrated: 21 surviving claims draw on 10 sources and one analyst produced about 38% of the claims, so a small number of contributors carry outsized influence. The high survival rate (98%) means the desk largely retained its initial assertions after debate, which strengthens internal consistency but also raises fragility to shared blind spots in those dominant sources.
Disconfirming evidence · base rates · falsifiers
Context
Outside consensus, and where this name already sits in your own portfolio.
Third-party consensus shown for context. It never enters Moneyta sentiment — when the two diverge, the debate above is where the why lives.
What this was built from
Every figure on this page traces to one of these. The desk reads only what is listed here — no outside knowledge, no browsing — and each card shows who read it and what it contributed to the score.
10 filings· 1 cited
SEC XBRL filings
Quarterly figures as filed with the SEC, read straight from EDGAR's structured data — not retyped or estimated.
Read by Mercer−0.1 to the score
1 holdings record
Fund holdings
Which funds hold this name and at what weight, plus insider Form 4 filings.
Read by Ellis+0.0 to the score
8 headlines· 2 cited
News coverage
Recent headlines about this company, rating chatter excluded and nothing published after the report date.
Read by Yatesnothing survived
1 computation
Valuation inputs
TTM cash-flow figures from the company's own XBRL filings, priced with the stored closing price. Implied growth and multiples only; no fair-value dollar figure reaches the desk, by design.
Read by Archercontext only
1 record· 0 cited
Company profile
Sector, industry and company details.
1 record· 0 cited
Analyst consensus
Third-party consensus, shown for context only — it never enters Moneyta sentiment.
Read means we pulled and handed it to an analyst; cited means a claim on this page points at it. Reading twelve quarters to state one trend is normal — the gap is shown rather than hidden.
Written by AI, checked against sources
The analysts, the bull–bear debate and the editor's note are AI agents reading only the evidence listed on this page. They can misread a filing or a headline, which is why every claim cites a source you can open and check yourself. The sentiment score is arithmetic over the claims that survived the debate, not a language model's opinion.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations. Past patterns do not indicate future results.
Get this for the tickers you actually hold
Plus the one thing no sample can show: how each name correlates with your portfolio, and what hides inside your funds.
The full terminal on SOLV Gold
Who holds it, who's buying, what the Street thinks: live behind the lock, updated as filings land.
Institutional holders
Net institutional flow, Q/Q
Largest holder position
Insider buys, 90 days
Clustered insider value
Street target range
The real figures are for members. Educational analysis, not advice.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations.